137 related articles for article (PubMed ID: 30150172)
1. Development and evaluation of immediate release diclofenac sodium suppositories.
Sultan T; Hamid S; Hassan S; Hussain K; Ahmed A; Bashir L; Naz S; Maqbool T
Pak J Pharm Sci; 2018 Sep; 31(5):1791-1795. PubMed ID: 30150172
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical characterization and in vivo evaluation of poloxamer-based solid suppository containing diclofenac sodium in rats.
Yong CS; Oh YK; Kim YI; Kim JO; Yoo BK; Rhee JD; Lee KC; Kim DD; Park YJ; Kim CK; Choi HG
Int J Pharm; 2005 Sep; 301(1-2):54-61. PubMed ID: 16024191
[TBL] [Abstract][Full Text] [Related]
3. [Effect of temperature on drug release and drug absorption in mixed type diclofenac sodium suppositories].
Iwata M; Takayama K; Takahashi Y; Obata Y; Machida Y; Nagai T; Shirotake S
Yakugaku Zasshi; 1999 Feb; 119(2):170-7. PubMed ID: 10067431
[TBL] [Abstract][Full Text] [Related]
4. Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.
Onyeji CO; Adebayo AS; Babalola CP
Eur J Pharm Sci; 1999 Dec; 9(2):131-6. PubMed ID: 10620725
[TBL] [Abstract][Full Text] [Related]
5. Sustained release of diclofenac from polymer-containing suppository and the mechanism involved.
Azechi Y; Ishikawa K; Mizuno N; Takahashi K
Drug Dev Ind Pharm; 2000 Nov; 26(11):1177-83. PubMed ID: 11068691
[TBL] [Abstract][Full Text] [Related]
6. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
Realdon N; Ragazzi E; Ragazzi E
Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
[TBL] [Abstract][Full Text] [Related]
7. New Formulation and Evaluation of Camptothecin Encapsulated and/or Dispersed Suppository.
Fatmi S; Taouzinet L; Lahiani-Skiba M; Skiba M; Iguer-Ouada M
Anticancer Agents Med Chem; 2021; 21(9):1183-1190. PubMed ID: 32885761
[TBL] [Abstract][Full Text] [Related]
8. Formulation, Physiochemical, and Microbial Assay of Henna Oil Vaginal Suppository Formulated with Polyethylene Glycol Bases.
Khazaeli P; Mehrabani M; Mosadegh A; Bios S; Zareshahi R; Moshafi MH
Iran J Med Sci; 2020 May; 45(3):207-213. PubMed ID: 32546887
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of diclofenac sodium buccoadhesive discs.
El-Samaligy MS; Yahia SA; Basalious EB
Int J Pharm; 2004 Nov; 286(1-2):27-39. PubMed ID: 15501000
[TBL] [Abstract][Full Text] [Related]
10. Preparation and In vitro Evaluation of Naproxen Suppositories.
Hargoli S; Farid J; Azarmi SH; Ghanbarzadeh S; Zakeri-Milani P
Indian J Pharm Sci; 2013 Mar; 75(2):143-8. PubMed ID: 24019561
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization and in vivo evaluation of thermosensitive diclofenac liquid suppository.
Yong CS; Choi YK; Kim YI; Park BJ; Quan QZ; Rhee JD; Kim CK; Choi HG
Arch Pharm Res; 2003 Feb; 26(2):162-7. PubMed ID: 12643595
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.
Woyczikowski B; Szulc J; Sznitowska M; Janicki S; Pilichowski J; Urbańska A
Acta Pol Pharm; 2003; 60(3):169-72. PubMed ID: 14556483
[TBL] [Abstract][Full Text] [Related]
13. Emulsions and rectal formulations containing myrrh essential oil for better patient compliance.
Etman M; Amin M; Nada AH; Shams-Eldin M; Salama O
Drug Discov Ther; 2011 Jun; 5(3):150-6. PubMed ID: 22466245
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
Ramakrishna S; Fadnavis NW; Diwan PV
Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
[TBL] [Abstract][Full Text] [Related]
15. Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.
Rodrigues F; Maia MJ; das Neves J; Sarmento B; Amaral MH; Oliveira MB
Drug Dev Ind Pharm; 2015; 41(9):1518-25. PubMed ID: 25265366
[TBL] [Abstract][Full Text] [Related]
16. Rectal bioavailability of amoxicillin sodium in rabbits: Effects of suppository base and drug dose.
Purohit TJ; Hanning SM; Amirapu S; Wu Z
J Control Release; 2021 Oct; 338():858-869. PubMed ID: 34534590
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
Uzunkaya G; Bergişadi N
Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
[TBL] [Abstract][Full Text] [Related]
19. Preparation and In Vivo Pharmacokinetics of the Tongshu Suppository.
Liu G; Dong L; Lu K; Liu S; Zheng Y
Biomed Res Int; 2016; 2016():1691579. PubMed ID: 27610366
[TBL] [Abstract][Full Text] [Related]
20. Salbutamol sulfate suppositories: influence of formulation on physical parameters and stability.
Taha EI; Zaghloul AA; Kassem AA; Khan MA
Pharm Dev Technol; 2003; 8(1):21-30. PubMed ID: 12665194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
